United Kingdom Change

Information for Medical Professionals

Taperloc®

An excellent combination of clinical success and durability explain why the Taperloc™ celebrated 25 years of service in 2007

Introduced in 1982 the Taperloc™ Hip System has provided over 25 years of unmatched clinical results1-5 and continues to deliver consistent, reproducible results. The Taperloc™ stem is designed after the European philosophy of a flat tapered wedge design. It has evolved to incorporate the Taperloc™ Microplasty stem to allow surgeons to address the growing demand to better address patient anatomies and facilitate multiple surgical techniques.


Key Features:

  • Over 25 years clinical success: the proven clinical history and durability of Taperloc™ provides a tried and tested implant
  • Taperloc™ and Taperloc™ Microplasty provides a system to better address all patient anatomies, provide bone conserving options and meet the demand for intermuscular and internervous surgical approaches
  • Advanced technologies: BoneMaster™ coating provides Taperloc™ with increased bone in-growth and enhanced fixation
  • Taperloc™ Hip system can be implanted using the muscle sparing anterior supine intramuscular (ASI) surgical approach. 
  • Taperloc™ hip system can be used as part of the Rapid Recovery programme for optimised patient recovery 
  • Taperloc™ Hip System can be implanted with all of the acetabular bearing options available from Biomet


Additional features:

  • Polished Cemented stems available alongside Porous Plasma Spray Coated Uncemented stems with their optional plasma spray HA coating
  • Standard and lateralised offsets, combined with 7 different neck lengths allows for better soft tissue tensioning and appropriate anatomy restoration without leg lengthening
  • Extensive modular head capabilities: Ceramic and metal head articulation on our Arcom™ polyethylene Metal on Metal articulation capabilities

Related Products: Exceed ABT™ and Magnum™


References

1. Total Hip Arthroplasty with an Uncemented Tapered Femoral Component. McLaughlin et. al. JBJS (Am) 2008: 90:1290-1296
2. The outcome of total hip replacement in obese and non-obese patients at 10 to 18 years. McLaughlin et. al. JBJS (Br) 2006;88-B:1286-92.
3. Primary Total Hip Arthroplasty with an Uncemented Femoral Component. A Long-Term Study of the Taperloc Stem. Parvizi,et. al. Journal of Arthroplasty Vol. 19 No. 2 2004
4. Cementless Femoral Fixation in the Rheumatoid Patient Undergoing Total Hip Arthroplasty Minimum 5-Year Results Keisu et. al. Journal of Arthroplasty Vol. 16 No. 4 2001
5. Primary Cementless Total Hip Arthroplasty in Octogenarians :2  to 11 year Follow-up. Keisu et. al.JBJS (Am) Vol.  83-A. No 3.  2001